Temasek Holdings (Private) LTD Coherus Bio Sciences, Inc. Transaction History
Temasek Holdings (Private) LTD
- $21.4 Billion
- Q2 2024
A detailed history of Temasek Holdings (Private) LTD transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 5,818,802 shares of CHRS stock, worth $6.05 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,818,802
Previous 7,381,116
21.17%
Holding current value
$6.05 Million
Previous $17.6 Million
42.94%
% of portfolio
0.05%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding CHRS
# of Institutions
143Shares Held
82.7MCall Options Held
79.1KPut Options Held
100K-
Black Rock Inc. New York, NY11.8MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$11 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$10.8 Million0.53% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.16 Million0.3% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.84MShares$2.96 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $80.8M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...